Standard
Baseline Cytogenetic Response Level Impact on Survival of Chronic Phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors as Third-Line Therapy : Real-World Data in Five Russian Centers. / Chitanava, Tamara; Lomaia, Elza; Shuvaev, Vasily; Martynkevich, Irina; Fominykh, Mikhail; Efremova, Elizaveta; Kersilova, Anna; Poshivay, Agniia-Polina; Koryagina, Elena; Ilyina, Natalia; Dorofeeva, Natalia; Medvedeva, Nadezhda; Klimovich, Anna; Shneider, Tatiana; Stepanova, Svetlana; Siordiya, Nadiya; Sbityakova, Eugenia; Lazorko, Natalia; Merzlikina, Olga; Polezhajkovskaya, Natalia; Zammoeva, Darina; Shnalieva, Nadezhda; Tochenaya, Elena; Zaritskey, Andrey.
в:
Clinical Lymphoma, Myeloma and Leukemia, Том 20, 09.2020, стр. S242-S242.
Результаты исследований: Научные публикации в периодических изданиях › тезисы › Рецензирование
Harvard
Chitanava, T, Lomaia, E, Shuvaev, V, Martynkevich, I
, Fominykh, M, Efremova, E, Kersilova, A, Poshivay, A-P, Koryagina, E, Ilyina, N, Dorofeeva, N, Medvedeva, N, Klimovich, A, Shneider, T, Stepanova, S, Siordiya, N, Sbityakova, E, Lazorko, N, Merzlikina, O, Polezhajkovskaya, N, Zammoeva, D, Shnalieva, N, Tochenaya, E & Zaritskey, A 2020, '
Baseline Cytogenetic Response Level Impact on Survival of Chronic Phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors as Third-Line Therapy: Real-World Data in Five Russian Centers',
Clinical Lymphoma, Myeloma and Leukemia, Том. 20, стр. S242-S242.
APA
Chitanava, T., Lomaia, E., Shuvaev, V., Martynkevich, I.
, Fominykh, M., Efremova, E., Kersilova, A., Poshivay, A-P., Koryagina, E., Ilyina, N., Dorofeeva, N., Medvedeva, N., Klimovich, A., Shneider, T., Stepanova, S., Siordiya, N., Sbityakova, E., Lazorko, N., Merzlikina, O., ... Zaritskey, A. (2020).
Baseline Cytogenetic Response Level Impact on Survival of Chronic Phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors as Third-Line Therapy: Real-World Data in Five Russian Centers.
Clinical Lymphoma, Myeloma and Leukemia,
20, S242-S242.
Vancouver
Author
Chitanava, Tamara ; Lomaia, Elza ; Shuvaev, Vasily ; Martynkevich, Irina
; Fominykh, Mikhail ; Efremova, Elizaveta ; Kersilova, Anna ; Poshivay, Agniia-Polina ; Koryagina, Elena ; Ilyina, Natalia ; Dorofeeva, Natalia ; Medvedeva, Nadezhda ; Klimovich, Anna ; Shneider, Tatiana ; Stepanova, Svetlana ; Siordiya, Nadiya ; Sbityakova, Eugenia ; Lazorko, Natalia ; Merzlikina, Olga ; Polezhajkovskaya, Natalia ; Zammoeva, Darina ; Shnalieva, Nadezhda ; Tochenaya, Elena ; Zaritskey, Andrey. /
Baseline Cytogenetic Response Level Impact on Survival of Chronic Phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors as Third-Line Therapy : Real-World Data in Five Russian Centers. в:
Clinical Lymphoma, Myeloma and Leukemia. 2020 ; Том 20. стр. S242-S242.
BibTeX
@article{58e2309e66374a52a4771a2778aa9b00,
title = "Baseline Cytogenetic Response Level Impact on Survival of Chronic Phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors as Third-Line Therapy: Real-World Data in Five Russian Centers",
keywords = "chronic myeloid leukemia, CML, tyrosine kinase inhibitor, TKI, third-line therapy, prognosis",
author = "Tamara Chitanava and Elza Lomaia and Vasily Shuvaev and Irina Martynkevich and Mikhail Fominykh and Elizaveta Efremova and Anna Kersilova and Agniia-Polina Poshivay and Elena Koryagina and Natalia Ilyina and Natalia Dorofeeva and Nadezhda Medvedeva and Anna Klimovich and Tatiana Shneider and Svetlana Stepanova and Nadiya Siordiya and Eugenia Sbityakova and Natalia Lazorko and Olga Merzlikina and Natalia Polezhajkovskaya and Darina Zammoeva and Nadezhda Shnalieva and Elena Tochenaya and Andrey Zaritskey",
year = "2020",
month = sep,
language = "Английский",
volume = "20",
pages = "S242--S242",
journal = "Clinical Lymphoma, Myeloma and Leukemia",
issn = "2152-2650",
publisher = "Cancer Media Group",
}
RIS
TY - JOUR
T1 - Baseline Cytogenetic Response Level Impact on Survival of Chronic Phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors as Third-Line Therapy
T2 - Real-World Data in Five Russian Centers
AU - Chitanava, Tamara
AU - Lomaia, Elza
AU - Shuvaev, Vasily
AU - Martynkevich, Irina
AU - Fominykh, Mikhail
AU - Efremova, Elizaveta
AU - Kersilova, Anna
AU - Poshivay, Agniia-Polina
AU - Koryagina, Elena
AU - Ilyina, Natalia
AU - Dorofeeva, Natalia
AU - Medvedeva, Nadezhda
AU - Klimovich, Anna
AU - Shneider, Tatiana
AU - Stepanova, Svetlana
AU - Siordiya, Nadiya
AU - Sbityakova, Eugenia
AU - Lazorko, Natalia
AU - Merzlikina, Olga
AU - Polezhajkovskaya, Natalia
AU - Zammoeva, Darina
AU - Shnalieva, Nadezhda
AU - Tochenaya, Elena
AU - Zaritskey, Andrey
PY - 2020/9
Y1 - 2020/9
KW - chronic myeloid leukemia
KW - CML
KW - tyrosine kinase inhibitor
KW - TKI
KW - third-line therapy
KW - prognosis
M3 - тезисы
VL - 20
SP - S242-S242
JO - Clinical Lymphoma, Myeloma and Leukemia
JF - Clinical Lymphoma, Myeloma and Leukemia
SN - 2152-2650
ER -
